Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schumann

Showing results (191-200 of 251) with videos related to

Pageof 26
Sort By:
The Journal of Biological Chemistry|February 21, 2003
Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involvedNicolas W J Schröder, Siegfried Morath, Christian Alexander, et al.
The Journal of Trauma and Acute Care Surgery|April 15, 2026
Hospital-based psychological consultation relates to post-discharge treatment engagement following violent injurySydney C Timmer-Murillo, Claire M Bird, Andrew T Schramm, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1996
Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activationN Lamping, A Hoess, B Yu, et al.
Lancet (London, England)|June 8, 1999
Endotoxin and immune activation in chronic heart failure: a prospective cohort studyJ Niebauer, H D Volk, M Kemp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosyChristopher M Johnson, Elizabeth A Lyle, Katherine O Omueti, et al.
The Journal of Infectious Diseases|September 10, 2003
Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole bloodSonja von Aulock, Nicolas W J Schröder, Katja Gueinzius, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 6, 2005
A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosisLutz Hamann, Abuzeid Gomma, Nicolas W J Schröder, et al.
Gut|January 27, 2007
Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coliM M Heimesaat, A Fischer, H-K Jahn, et al.
Critical Care Medicine|February 10, 2000
Lipopolysaccharide binding protein in acute pancreatitisP J Erwin, H Lewis, S Dolan, et al.
Plos One|July 24, 2008
CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individualDjin-Ye Oh, Heiko Jessen, Claudia Kücherer, et al.
Pageof 26

Showing results (191-200 of 251) with videos related to

Sort By:
Pageof 26
The Journal of Biological Chemistry|February 21, 2003
Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involvedNicolas W J Schröder, Siegfried Morath, Christian Alexander, et al.
The Journal of Trauma and Acute Care Surgery|April 15, 2026
Hospital-based psychological consultation relates to post-discharge treatment engagement following violent injurySydney C Timmer-Murillo, Claire M Bird, Andrew T Schramm, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1996
Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activationN Lamping, A Hoess, B Yu, et al.
Lancet (London, England)|June 8, 1999
Endotoxin and immune activation in chronic heart failure: a prospective cohort studyJ Niebauer, H D Volk, M Kemp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosyChristopher M Johnson, Elizabeth A Lyle, Katherine O Omueti, et al.
The Journal of Infectious Diseases|September 10, 2003
Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole bloodSonja von Aulock, Nicolas W J Schröder, Katja Gueinzius, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 6, 2005
A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosisLutz Hamann, Abuzeid Gomma, Nicolas W J Schröder, et al.
Gut|January 27, 2007
Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coliM M Heimesaat, A Fischer, H-K Jahn, et al.
Critical Care Medicine|February 10, 2000
Lipopolysaccharide binding protein in acute pancreatitisP J Erwin, H Lewis, S Dolan, et al.
Plos One|July 24, 2008
CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individualDjin-Ye Oh, Heiko Jessen, Claudia Kücherer, et al.
Pageof 26